StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) income statement

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.27−0.02 (-0.47%)

Close on Nov 18, 2026Market cap $1.53BP/E –Yield –

Precigen, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
–
Operating margin
-1141.1%
Net margin
-1628.5%
Return on equity, FY2025
-843.6%

Financial strength

Current ratio
4.58
Debt to equity
2.15
Debt to assets
55.1%
Cash to current liabilities
55.6%

Valuation

P/E ratio
–
Price to sales
–
Price to book
35.08
Dividend yield
–

See a number that looks wrong?